Patent Assignment
Reel/Frame 055429/0630
Merger
Recorded: 2021-02-26
Pages: 5
Assignor
DISTRIBUTED BIO, INC.
Executed: 2020-12-31
Assignee
CHARLES RIVER LABORATORIES, INC.
251 BALLARDVALE STREET, WILMINGTON, MASSACHUSETTS, 01887
Covered Properties
(2)
Anti-Sars-COV2 Antibodies Derived from CR3022
Application:
63/014,546 →
Anti-Sars-Cov-2 Antibodies Derived from CR3022
Patent:
11,034,762 →
Application:
15/931,649 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 26, 2021
From: GLANVILLE, JACOB; DARAEIKIA, SHAHRAD; WANG, I-CHIEH; LIAO CHAN, SINDY ANDREA
To: DISTRIBUTED BIO, INC.
Reel/Frame 055541/0458 →
Assignment of Assignor's Interest
Feb 26, 2021
From: GLANVILLE, JACOB; DARAEIKIA, SHAHRAD; WANG, I-CHIEH; LIAO CHAN, SINDY ANDREA
To: DISTRIBUTED BIO, INC.
Reel/Frame 055645/0033 →
Assignment of Assignor's Interest
Mar 23, 2021
From: CHARLES RIVER LABORATORIES, INC.
To: CENTIVAX, INC.
Reel/Frame 055690/0403 →